drugset / Trial / NCT07277257

Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome

NCT07277257 ↗

Phase 4 Recruiting 35 enrolled Center For Sight
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the effect of TRYPTYR in patients with Sjögren's syndrome-related dry eye disease. The goal is to determine whether TRYPTYR can improve symptoms and signs of dry eye in this specific patient population.

Timeline

Start
2025-12-02
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Acoltremon Small molecule 0.003 % Other

Indications